Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alejandro Barbagelata

Showing results (21-30 of 60) with videos related to

Pageof 6
Sort By:
Drugs in Context|January 20, 2023
Emerging concepts in heart failure management and treatment: focus on current guideline-directed medical therapy for heart failure with reduced ejection fractionOscar Eduardo Ospina González, Diana Catalina Llanos Mejía, Edgardo Kaplinsky, et al.
The American Journal of Cardiology|August 28, 2007
Meta-analysis of published reports on the effect of statin treatment before percutaneous coronary intervention on periprocedural myonecrosisRamanna Merla, Nischita K Reddy, Fen-Wei Wang, et al.
Drugs in Context|January 20, 2023
Emerging concepts in heart failure management and treatment: focus on point-of-care ultrasound in cardiogenic shockMariela Ruben, María Sol Molinas, Hugo Paladini, et al.
Drugs in Context|January 20, 2023
Emerging concepts in heart failure management and treatment: focus on tachycardia-induced cardiomyopathyMaría Victoria Báez Cabanillas, Roberto Colque, Miguel Ángel Tibaldi, et al.
Expert Review of Cardiovascular Therapy|April 22, 2009
Management of hypertension in chronic heart failureSaraswathy Manickavasagam, Ramanna Merla, Michael M Koerner, et al.
Cardiology Journal|December 11, 2012
Management of arrhythmias in heart failure. What a practicing physician should know in the current timesRajesh Ramineni, Mani Kumar Bheemarasetti, Adrian Baranchuk, et al.
Texas Heart Institute Journal|March 5, 2010
Hypothyroidism and renal function in patients with systolic heart failureRamanna Merla, Juan D Martinez, Milagros A Martinez, et al.
American Heart Journal|February 21, 2003
Rationale and study design for a multicenter, randomized, double-blind, placebo-controlled study of the effects of tolvaptan on the acute and chronic outcomes of patients hospitalized with worsening congestive heart failureMihai Gheorghiade, Wendy A Gattis, Alejandro Barbagelata, et al.
American Heart Journal|September 11, 2013
The left bundle-branch block puzzle in the 2013 ST-elevation myocardial infarction guideline: from falsely declaring emergency to denying reperfusion in a high-risk population. Are the Sgarbossa Criteria ready for prime time?Qiangjun Cai, Nilay Mehta, Elena B Sgarbossa, et al.
Heart & Lung : the Journal of Critical Care|October 27, 2025
Efficacy of cardiac myosin activators compared to placebo in patients with heart failure and reduced ejection fraction: A systematic review and meta-analysis of randomized controlled trialsMiguel A Samaniego-Laguna, Andrea Tripoli, Norma N Gamarra-Valverde, et al.
Pageof 6

Showing results (21-30 of 60) with videos related to

Sort By:
Pageof 6
Drugs in Context|January 20, 2023
Emerging concepts in heart failure management and treatment: focus on current guideline-directed medical therapy for heart failure with reduced ejection fractionOscar Eduardo Ospina González, Diana Catalina Llanos Mejía, Edgardo Kaplinsky, et al.
The American Journal of Cardiology|August 28, 2007
Meta-analysis of published reports on the effect of statin treatment before percutaneous coronary intervention on periprocedural myonecrosisRamanna Merla, Nischita K Reddy, Fen-Wei Wang, et al.
Drugs in Context|January 20, 2023
Emerging concepts in heart failure management and treatment: focus on point-of-care ultrasound in cardiogenic shockMariela Ruben, María Sol Molinas, Hugo Paladini, et al.
Drugs in Context|January 20, 2023
Emerging concepts in heart failure management and treatment: focus on tachycardia-induced cardiomyopathyMaría Victoria Báez Cabanillas, Roberto Colque, Miguel Ángel Tibaldi, et al.
Expert Review of Cardiovascular Therapy|April 22, 2009
Management of hypertension in chronic heart failureSaraswathy Manickavasagam, Ramanna Merla, Michael M Koerner, et al.
Cardiology Journal|December 11, 2012
Management of arrhythmias in heart failure. What a practicing physician should know in the current timesRajesh Ramineni, Mani Kumar Bheemarasetti, Adrian Baranchuk, et al.
Texas Heart Institute Journal|March 5, 2010
Hypothyroidism and renal function in patients with systolic heart failureRamanna Merla, Juan D Martinez, Milagros A Martinez, et al.
American Heart Journal|February 21, 2003
Rationale and study design for a multicenter, randomized, double-blind, placebo-controlled study of the effects of tolvaptan on the acute and chronic outcomes of patients hospitalized with worsening congestive heart failureMihai Gheorghiade, Wendy A Gattis, Alejandro Barbagelata, et al.
American Heart Journal|September 11, 2013
The left bundle-branch block puzzle in the 2013 ST-elevation myocardial infarction guideline: from falsely declaring emergency to denying reperfusion in a high-risk population. Are the Sgarbossa Criteria ready for prime time?Qiangjun Cai, Nilay Mehta, Elena B Sgarbossa, et al.
Heart & Lung : the Journal of Critical Care|October 27, 2025
Efficacy of cardiac myosin activators compared to placebo in patients with heart failure and reduced ejection fraction: A systematic review and meta-analysis of randomized controlled trialsMiguel A Samaniego-Laguna, Andrea Tripoli, Norma N Gamarra-Valverde, et al.
Pageof 6